Leaderboards/Renal Transplantation Outcomes and Treatments

Renal Transplantation Outcomes and Treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Thibaut Vaulet
KU Leuven
2
Elisabet Van Loon
KU Leuven
3
Surabhi R. Madhvapathy
Northwestern University
4
Rachel Fieldhouse
NatureServe
5
Aleksandar Senev
Northwestern University
6
Griffith B. Perkins
South Australia Pathology
7
Suzanne Bezstarosti
Leiden University Medical Center
8
Bree Shi
The University of Sydney
9
Francesco Lasorsa
University of Bari Aldo Moro
10
Quinn Rafferty
Institute for Health Metrics and Evaluation

Papers

1
Miniaturized implantable temperature sensors for the long-term monitoring of chronic intestinal inflammation
Nature Biomedical Engineering|2024
71 cit.
2
Publication in The Lancet Global Health (2025) [66 citations, W4412581579]
The Lancet Global Health|2025
66 cit.
3
Publication in International Journal of Molecular Sciences (2024) [60 citations, W4394807907]
International Journal of Molecular Sciences|2024
60 cit.
4
Publication in Minerva Urology and Nephrology (2025) [10 citations, W4409942536]
Minerva Urology and Nephrology|2025
10 cit.
5
Continuous indices to assess the phenotypic spectrum of kidney transplant rejection
Nature Communications|2025
10 cit.
6
Publication in World Journal of Urology (2024) [8 citations, W4405379909]
World Journal of Urology|2024
8 cit.
7
HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation
Frontiers in Immunology|2024
6 cit.
8
Active immunologic participation and metabolic shutdown of kidney structural cells during kidney transplant rejection
American Journal of Transplantation|2024
5 cit.
9
Stronger together: the power of cross-organ data sets for improved allograft study outcomes
Kidney International|2024
3 cit.
10
Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?
Frontiers in Genetics|2024
3 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Iwijn De Vlaminck
Cornell University
2
Christopher G. Kanakry
National Cancer Institute
3
Kathleen Dooling
Pfizer (United States)
4
R. Woodward
Medical Care Development
5
M. Chahdi Beltrame
Hospital El Cruce
6
Roxane D. Staiger
University of Lucerne
7
Lauren Callans
University of Pennsylvania
8
Ruoyun Tan
Jiangsu Province Hospital
9
Julia Beck
University of Basel
10
Yingzi Ming
Central South University

Papers

1
Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
MMWR Morbidity and Mortality Weekly Report|2022
236 cit.
2
Spatial mapping of the total transcriptome by in situ polyadenylation
Nature Biotechnology|2022
102 cit.
3
Spatiotemporal transcriptomics reveals pathogenesis of viral myocarditis
Nature Cardiovascular Research|2022
67 cit.
4
Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation
Proceedings of the National Academy of Sciences|2022
49 cit.
5
A spatiotemporal molecular atlas of the ovulating mouse ovary
Proceedings of the National Academy of Sciences|2024
43 cit.
6
Spatial mapping of mobile genetic elements and their bacterial hosts in complex microbiomes
Nature Microbiology|2024
41 cit.
7
Clinical Manifestations of Varicella: Disease Is Largely Forgotten, but It's Not Gone
The Journal of Infectious Diseases|2022
37 cit.
8
A metagenomic DNA sequencing assay that is robust against environmental DNA contamination
Nature Communications|2022
33 cit.
9
Posttransplantation cyclophosphamide expands functional myeloid-derived suppressor cells and indirectly influences Tregs
Blood Advances|2023
33 cit.
10
Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation
Frontiers in Immunology|2022
32 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Philip F. Halloran
University of Alberta
2
Dorry L. Segev
New York University
3
Josef Stehlik
Intermountain Medical Center
4
Bruce Kaplan
University of Colorado Anschutz Medical Campus
5
Mark D. Stegall
Mayo Clinic in Arizona
6
Robert M. Merion
University of Kansas Medical Center
7
Arthur J. Matas
University of Minnesota
8
Michael Mengel
University of Alberta
9
Peter Nickerson
Shared Services Canada
10
Minnie Sarwal
Stanford University

Papers

1
Chronic Renal Failure after Transplantation of a Nonrenal Organ
New England Journal of Medicine|2003
2.2k cit.
2
Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index
American Journal of Transplantation|2006
1.9k cit.
3
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
New England Journal of Medicine|2007
1.8k cit.
4
Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence
American Journal of Transplantation|2011
1.6k cit.
5
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
American Journal of Transplantation|2014
1.3k cit.
6
Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era
American Journal of Transplantation|2004
1.3k cit.
7
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size match
The Journal of Heart and Lung Transplantation|2019
1.3k cit.
8
Long-Term Consequences of Kidney Donation
New England Journal of Medicine|2009
1k cit.
9
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
American Journal of Transplantation|2017
1k cit.
10
Risk of End-Stage Renal Disease Following Live Kidney Donation
JAMA|2014
978 cit.

Reagents for Renal Transplantation Outcomes and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 64

MUC1 (D9O8K) Rabbit Monoclonal Antibody

#14161$197,466
View Evidence →
Cell Signaling TechnologyEvidence 66

Phospho-Bim (Ser77) (D4H12) Rabbit Monoclonal Antibody

#12433$176,415
View Evidence →
Cell Signaling TechnologyEvidence 64

Phospho-ATF-2 (Thr71)/ATF-7 (Thr53) (A8J7P) Rabbit Monoclonal Antibody

#15411$176,415
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 68

Synapsin Antibody

#2312$317
View Evidence →
Cell Signaling TechnologyEvidence 61

CELSR2 (D2M9H) Rabbit Monoclonal Antibody (BSA and Azide Free)

#19983$865
View Evidence →
Cell Signaling TechnologyEvidence 64

NEDD4 (D82F4) Rabbit Monoclonal Antibody

#5344$161,351
View Evidence →